India may witness outsourcing boom in pharma
India's low cost operations and ability make cheaper versions of generic drugs has made it an attractive destination for global pharma industry, which is eyeing India as a potential hub for outsourcing operation to offset a slowdown in other markets. India offers technical skills and low cost advantage and has over 100 US FDA approved plants. Indian outsourcing market is seen at $40-50 billion.
